Abercrombie George B

Avg. Two Year Performance

163% Avg. Purchase Return
62% Compound
1% Avg. Sale Return
1% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(3%)57%90%219%163%
Purchase Success Rate1 of 22 of 22 of 22 of 22 of 2
Average Sale Return(1%)(< 1%)(< 1%)< 1%1%
Sale Success Rate1 of 82 of 81 of 82 of 84 of 8
Drugs » Biotechnology

CHIEF EXECUTIVE OFFICER, Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Sr. VP & Chief Comm. Officer:

Holdings: 285.48K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 36.43K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Other

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 25.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Major

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--